Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2011, Article ID 128402, 8 pages
http://dx.doi.org/10.1155/2011/128402
Research Article

Anti-Hyperglycemic Properties of Crude Extract and Triterpenes from Poria cocos

1Agricultural Biotechnology Research Center, Academia Sinica, Taipei 115, Taiwan
2Department and Institute of Pharmacology, National Yang-Ming University, Taipei 112, Taiwan
3Department of Veterinary Medicine, National Chung Hsing University, Taichung, Taiwan
4Institute of Zoology, National Taiwan University, Taipei 10617, Taiwan
5Department of Life Sciences, National Chung Hsing University, Taichung, Taiwan

Received 1 April 2010; Accepted 7 August 2010

Copyright © 2011 Tzu-Hsuan Li et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. P. Boyle, M. M. Engelgau, T. J. Thompson et al., “Estimating prevalence of type 1 and type 2 diabetes in a population of African Americans with diabetes mellitus,” American Journal of Epidemiology, vol. 149, no. 1, pp. 55–63, 1999. View at Google Scholar · View at Scopus
  2. A. S. Attele, Y.-P. Zhou, J.-T. Xie et al., “Antidiabetic effects of Panax ginseng berry extract and the identification of an effective component,” Diabetes, vol. 51, no. 6, pp. 1851–1858, 2002. View at Google Scholar · View at Scopus
  3. M. Laakso, “Insulin resistance and its impact on the approach to therapy of type 2 diabetes,” International Journal of Clinical Practice, Supplement, no. 121, pp. 8–12, 2001. View at Google Scholar · View at Scopus
  4. T. H.-W. Huang, B. P. Kota, V. Razmovski, and B. D. Roufogalis, “Herbal or natural medicines as modulators of peroxisome proliferator-activated receptors and related nuclear receptors for therapy of metabolic syndrome,” Basic and Clinical Pharmacology and Toxicology, vol. 96, no. 1, pp. 3–14, 2005. View at Publisher · View at Google Scholar · View at Scopus
  5. A. Y. Y. Cheng and I. G. Fantus, “Oral antihyperglycemic therapy for type 2 diabetes mellitus,” Canadian Medical Association Journal, vol. 172, no. 2, pp. 213–226, 2005. View at Publisher · View at Google Scholar · View at Scopus
  6. H. C. S. Howlett and C. J. Bailey, “A risk-benefit assessment of metformin in type 2 diabetes mellitus,” Drug Safety, vol. 20, no. 6, pp. 489–503, 1999. View at Publisher · View at Google Scholar · View at Scopus
  7. J. Q. Purnell and C. Weyer, “Weight effect of current and experimental drugs for diabetes mellitus: from promotion to alleviation of obesity,” Treatments in Endocrinology, vol. 2, no. 1, pp. 33–47, 2003. View at Publisher · View at Google Scholar · View at Scopus
  8. A. J. Krentz and C. J. Bailey, “Oral antidiabetic agents: current role in type 2 diabetes mellitus,” Drugs, vol. 65, no. 3, pp. 385–411, 2005. View at Publisher · View at Google Scholar · View at Scopus
  9. G. Z. Bi Zhishu and L. Taihui, The Macrofungus Flora of China's Guangdong Province, The Chinese University Press, Hong Kong, 1997.
  10. E. Boa, Wild Edible Fungi: A Global Overview of Their Use and Importance to People, Food & Agriculture Organization of the UN, 2004.
  11. S. Li, Compendium of Materia Medica: Bencao Gangmu Beijing, Foreign Languages Press, Beijing, China, 2003.
  12. P. M. Kirk, P. F. Cannon, D. W. Minter, and J. A. Stalpers, Dictionary of the Fungi, CABI Publishing, Wallingford, UK, 2008.
  13. W. Jia, W. Gaoz, and L. Tang, “Antidiabetic herbal drugs officially approved in China,” Phytotherapy Research, vol. 17, no. 10, pp. 1127–1134, 2003. View at Publisher · View at Google Scholar · View at Scopus
  14. U. Lindequist, T. H. J. Niedermeyer, and W.-D. Jülich, “The pharmacological potential of mushrooms,” Evidence-Based Complementary and Alternative Medicine, vol. 2, no. 3, pp. 285–299, 2005. View at Publisher · View at Google Scholar · View at Scopus
  15. W. L. Li, H. C. Zheng, J. Bukuru, and N. De Kimpe, “Natural medicines used in the traditional Chinese medical system for therapy of diabetes mellitus,” Journal of Ethnopharmacology, vol. 92, no. 1, pp. 1–21, 2004. View at Publisher · View at Google Scholar · View at Scopus
  16. T. Tai, A. Akahori, and T. Shingu, “A lanostane triterpenoid from Poria cocos,” Phytochemistry, vol. 31, no. 7, pp. 2548–2549, 1992. View at Google Scholar · View at Scopus
  17. H. P. Molitoris, “Mushrooms in medicine,” Folia Microbiologica, vol. 39, no. 2, pp. 91–98, 1994. View at Publisher · View at Google Scholar · View at Scopus
  18. P. C.-K. Cheung, “Dietary fibre content and composition of some edible fungi determined by two methods of analysis,” Journal of the Science of Food and Agriculture, vol. 73, no. 2, pp. 255–260, 1997. View at Publisher · View at Google Scholar · View at Scopus
  19. J. K. Zjawiony, “Biologically active compounds from Aphyllophorales (polypore) fungi,” Journal of Natural Products, vol. 67, no. 2, pp. 300–310, 2004. View at Publisher · View at Google Scholar · View at Scopus
  20. M. Sato, T. Tai, Y. Nunoura, Y. Yajima, S. Kawashima, and K. Tanaka, “Dehydrotrametenolic acid induces preadipocyte differentiation and sensitizes animal models of noninsulin-dependent diabetes mellitus to insulin,” Biological & Pharmaceutical Bulletin, vol. 25, no. 1, pp. 81–86, 2002. View at Google Scholar · View at Scopus
  21. L. Chen, D. Wang, J. Wu, B. Yu, and D. Zhu, “Identification of multiple constituents in the traditional Chinese medicine formula GuiZhiFuLing-Wan by HPLC-DAD-MS/MS,” Journal of Pharmaceutical and Biomedical Analysis, vol. 49, no. 2, pp. 267–275, 2009. View at Publisher · View at Google Scholar · View at Scopus
  22. T. Tai, A. Akahori, and T. Shingu, “Triterpenes of Poria cocos,” Phytochemistry, vol. 32, no. 5, pp. 1239–1244, 1993. View at Google Scholar · View at Scopus
  23. T. Tai, T. Shingu, T. Kikuchi, Y. Tezuka, and A. Akahori, “Triterpenes from the surface layer of Poria cocos,” Phytochemistry, vol. 39, no. 5, pp. 1165–1169, 1995. View at Publisher · View at Google Scholar · View at Scopus
  24. T. Nakagawa, A. Tsuchida, Y. Itakura et al., “Brain-derived neurotrophic factor regulates glucose metabolism by modulating energy balance in diabetic mice,” Diabetes, vol. 49, no. 3, pp. 436–444, 2000. View at Google Scholar · View at Scopus
  25. Y.-J. Hsu, T.-H. Lee, C. L.-T. Chang, Y.-T. Huang, and W.-C. Yang, “Anti-hyperglycemic effects and mechanism of Bidens pilosa water extract,” Journal of Ethnopharmacology, vol. 122, no. 2, pp. 379–383, 2009. View at Publisher · View at Google Scholar · View at Scopus
  26. S.-L. Chang, C. L.-T. Chang, P.-I. Huang, M.-H. Tao, and W.-C. Yang, “Role of Cybr, a cytohesin binder and regulator, in CD4+ T-cell function and host immunity,” Molecular Immunology, vol. 46, no. 16, pp. 3218–3223, 2009. View at Publisher · View at Google Scholar · View at Scopus
  27. S. Samane, J. Noël, Z. Charrouf, H. Amarouch, and P. S. Haddad, “Insulin-sensitizing and anti-proliferative effects of Argania spinosa seed extracts,” Evidence-Based Complementary and Alternative Medicine, vol. 3, no. 3, pp. 317–327, 2006. View at Publisher · View at Google Scholar · View at Scopus
  28. J.-T. Hwang, M.-S. Lee, H.-J. Kim et al., “Antiobesity effect of ginsenoside Rg3 involves the AMPK and PPAR-γ signal pathways,” Phytotherapy Research, vol. 23, no. 2, pp. 262–266, 2009. View at Publisher · View at Google Scholar · View at Scopus